As one of the world's leading universities, the University of British Columbia creates an exceptional learning environment that fosters global citizenship, advances a civil and sustainable society, and supports outstanding research to serve the people of British Columbia, Canada and the world.

Dr. Cajiao developed a mathematical model that streamlined the drug discovery process for a neutralizing agent to the anticoagulant fondaparinux. Since fondaparinux is a superior alternative to current anticoagulants, this research will greatly impact the health care system, the therapeutic field, and patient safety.

A randomly-selected Doctoral citation each day: today from the Doctor of Philosophy in Biomedical Engineering (PhD) - graduated in 2013